Alan J Russell sold Edgewise Therapeutics, Inc. (EWTX) stock

Alan J Russell, Chief Scientific Officer of Edgewise Therapeutics, Inc. (EWTX), sold 200,000 shares of EWTX stock, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 1, 2026, 1 day before it was made public.

EWTX has moved +14.0% since the trade date, from $39.15 to $44.64 (Sep 21, 2026 close).